Topic highlights include: FDA considers major shift in COVID vaccine strategy, DNA from blood samples could help early cancer detection, Wisconsin researchers say, CDC informs staff of reorganization after pandemic criticisms

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., and William Morice II, M.D., Ph.D., provide an update on this year’s triple-demic of respiratory viruses, discuss the future of at-home testing, and preview future pandemic preparedness efforts.

This weeks research roundup features: Automated scoring of total inflammation in renal allograft biopsies

William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, joins Bobbi Pritt, M.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic. In this episode, they kick off the new year with a legislative update and discuss at-home testing options in the wake of the new subvariant of COVID-19.

Mayo Clinic Laboratories is committed to innovation that provides the right test at the right time for the right patients. That effort always starts with identifying gaps in patient care. Filling those gaps sometimes involves not developing new tests but finding ways to make existing tests more efficient and easier for patients.

Mayo Clinic Laboratories is excited to announce our participation in Medlab Middle East 2023, a medical conference and exhibition taking place in Dubai, United Arab Emirates, Feb. 6–9, 2023.

PACE / State of CA / State of FLHave you ever wondered how we came from bloodletting and leeches to present day phlebotomy? This presentation is going to walk you through the history and what has led us to some of the advancements in the field of phlebotomy including safety and regulations.

Mayo Clinic Laboratories, a leading reference laboratory, and Helix, the nation’s leading population genomics and viral surveillance company, today announced a new strategic collaboration that will provide life sciences customers access to a comprehensive joint laboratory offering for research and development initiatives across the drug development lifecycle. 

This week's research roundup features: Drug testing in support of the diagnosis of neonatal abstinence syndrome: The current situation

Laboratory outreach is subject to many rules and regulations. It’s a herculean task to become fluent and then remain current in the ever-changing health care environment. Because of the broad nature of laboratory outreach, there is no single source of knowledge. Read now to find out the most frequent questions.

For Billy Dowell Jr., a competitive golfer, focus, determination, and course correction are essential to excelling at the sport. These skills, along with routine follow-up care and testing, are also important to navigating a life impacted by multiple chronic autoimmune conditions.

In this month's "Hot Topic," Linnea Baudhuin, Ph.D., discusses Mayo Clinic Laboratories’ up-to-date gene panel tests for cardiomyopathies and arrhythmias, connective tissue and vascular fragility disorders, dyslipidemias, and congenital heart disease.

Mayo Clinic Laboratories, a leader in gastroenterology and patient care, will be exhibiting at the Crohn's & Colitis Congress, a premier conference for health care professionals and researchers interested in inflammatory bowel disease (IBD). Mayo Clinic Laboratories offers a comprehensive IBD test menu, including evaluations to diagnose, differentiate, and manage therapies to treat the condition.

Topic highlights include: Public health agencies try to restore trust as they fight misinformation, Telehealth brings expert sexual assault exams to rural patients, FDA decision on experimental Alzheimer’s drug expected this week.

In this episode of “Lab Medicine Rounds,” Justin Kreuter, M.D., sits down with R. Ross Reichard, M.D., a forensic pathologist at Mayo Clinic and associate professor of laboratory medicine and pathology, to discuss what every pathologist should know about the legal system.